UK NHS appoints chair of new Commissioning Board
This article was originally published in Clinica
The UK Department of Health has appointed Malcolm Grant chair of the NHS Commissioning Board, the body that will oversee the delivery of healthcare services worth annually around £60bn ($95bn) under the reformed NHS.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.